Do the data support the comorbidity hypothesis for the prostate, lung, colorectal, and ovarian cancer screening trial results?

Journal of Clinical Oncology

Volumn 29, Issue 13, 2011, Pages

  Bach, Peter B ^a   Vickers, Andrew J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER SCREENING; CANCER SURVIVAL; COLORECTAL CANCER; COMORBIDITY; DEATH; HUMAN; HYPOTHESIS; LETTER; LIFE EXPECTANCY; LUNG CANCER; OVARY CANCER; POST HOC ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; PUBLICATION; RISK ASSESSMENT;

COMORBIDITY; HUMANS; MALE; MASS SCREENING; MODELS, BIOLOGICAL; PROSTATIC NEOPLASMS;

EID: 79955614531     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.34.9027     Document Type: Letter

References (1)

1. Crawford ED, Grubb R 3rd, Black A, et al: Comorbidity and mortality results from a randomized prostate cancer screening trial. J Clin Oncol 29:355-361, 2011